Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. annual/quarterly long term debt history from 2018 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Aclaris Therapeutics, Inc. long term debt for the quarter ending December 31, 2020 were 10.7M, a 64.39% decrease year-over-year.
- Aclaris Therapeutics, Inc. long term debt for 2020 were 10.7M, a 64.39% decrease from 2018.
- Aclaris Therapeutics, Inc. long term debt for 2018 were 29.9M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aclaris Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $11 |
| 2018 | $30 |
| Aclaris Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2020-12-31 | $11 |
| 2018-12-31 | $30 |
Aclaris Therapeutics, Inc. Long Term Debt — FAQ
Aclaris Therapeutics, Inc. (ACRS) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's long term debt history?
The chart and table above show Aclaris Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.